- Home
- Companies
- switzerland
- pharmaceutical development
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Manufacturing, Other
- Environmental
- Health and Safety
- Water and Wastewater
- Air and Climate
- Food and Beverage
- Energy
- Soil and Groundwater
- Aerospace & Air Transport
- Glassware
- Waste and Recycling
- Agriculture
- University / Academia / Research
- Banking & Finance / Insurance / Legal
- Defense
- Retail
- Paint
- Plastics & Resins
- Oil, Gas & Refineries
- Government
- Construction & Construction Materials
Pharmaceutical Development Suppliers Serving Switzerland
151 companies found
based inSan Francisco, CALIFORNIA (USA)
The invenious platform aims to enhance safety, efficacy, sterility, value and convenience. BioQ designs ready-to-use delivery systems for hard to prepare and hard to administer infusible drugs – thereby simplifying the infusion process from ...
based inIrving, TEXAS (USA)
Celanese (NYSE: CE) is a global chemical and specialty materials company that engineers and manufactures a wide variety of products essential to everyday living. Celanese is built on the tradition of using our expertise – chemical intermediates, ...
based in, GERMANY
betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...
betaSENSE has developed a cutting-edge platform technology leveraging the principles of infrared spectroscopy to advance diagnostics in neurodegenerative disorders. The technology, known as betaSENSE, utilizes differential ...
based inAndernach, GERMANY
Since 1984 we have been focused on utilizing our expertise, experience and innovation to create market leading drug delivery solutions for our pharmaceutical partners. As a trusted technology partner for the pharmaceutical industry, we develop and ...
based inBasel, SWITZERLAND
Aurealis Therapeutics, a Swiss-Finnish private biopharmaceutical company, is now entering the clinical trial phase with its patented three-in-one combination product AUP-16 for chronic non-healing wounds and other regenerative diseases. The ...
based inStockholm, SWEDEN
IBT is a pharmaceutical company with its registered office in Stockholm with a vision to develop drugs influencing the human infant microbiome, and thereby prevent or treat rare diseases affecting premature infants. IBT is currently developing its ...
IBP-9414 for the prevention of necrotizing enterocolitis (NEC) contains the active substance Lactobacillus reuteri, which is a co-evolved human bacterial strain naturally present in breast milk. Lactobacillus reuteri is a live bacteria known to be ...
based inSalt Lake City, UTAH (USA)
Echelon Biosciences, Inc (EBI) was founded as Echelon Research Labs by two professors from the University of Utah. Their initial goal was to advance the science of lipid signaling by developing novel research reagents, assays, and ultimately ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
based inDeep River, CONNECTICUT (USA)
COLANAR specializes in creating advanced liquid filling systems and automated handling for pharmaceutical and biotech sectors, catering to a global clientele. The company's dedication is evident in its novel solutions tailored for the Life Sciences ...
The CMC 1000 is a compact benchtop crimp capping machine specifically designed for pharmaceutical applications involving aluminum crimp caps. This device is engineered to accommodate all aluminum cap styles, featuring a stainless steel exterior to ...
based inNew York City, NEW YORK (USA)
Lauren Sciences is a privately-held New York biotechnology company focused on developing its V-Smart platform to create a robust pipeline of V-Smart therapeutics consisting of central nervous system (CNS)-active drugs that normally do not cross the ...
V-Smart Platform, breakthrough innovation, winning trifecta for brain delivery, enables non-invasive, triple-targeted CNS delivery of non-BBB penetrant therapeutic agents (nucleic acids, antibodies, biologics, small molecules, ...
based inJurupa Valley, CALIFORNIA (USA)
CryoWorks provides a wide range of products for the storage, distribution and transfer of cryogenic fluids. CryoWorks provides a variety of products for the storage, distribution, and transfer of cryogenic fluids. For all of your cryogenic needs, ...
based inSaint-Maur-des-Fossés, FRANCE
Since its foundation in 1932, Septodont has been at the forefront of pharmaceutical dentistry developing, manufacturing and distributing a wide range of high quality dental products all over the world. Looking to the future, Septodont is also ...
Innovation is part of our company’s identity and we continuously strive to bring new solutions to the markets we serve. In that perspective and based on our core competencies in injectable and semi-solid pharmaceutical ...
based inCambridge, MASSACHUSETTS (USA)
Portal Instruments is developing a needle-free drug delivery platform for effortless delivery and a transformed patient experience. Portal’s platform is in development and not available for sale or use. Portal Instruments is focused on needle-free ...
based inYokohama, JAPAN
MabGenesis Inc. is a biopharmaceutical startup that uses 30+ years of antibody research to provide first-in-class and best-in-class therapeutic monoclonal antibody drugs for humans and animals. We have the world’s highest quality antibody libraries ...
based inNanjing, CHINA
Nanjing Hjchem company provides a solution for every stage of your research processing. We work together various researchers and scientists from laboratory to pilot plant and production scale. Our experienced systems are designed for different ...
based inLondon, UNITED KINGDOM
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, ...
based inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
T3 Pharma has developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviours of live bacteria. The genetically engineered bacteria selectively target solid tumors, where they deliver chosen protein payloads ...
based inSomerville, MASSACHUSETTS (USA)
Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted ...
In collaboration with Takeda Pharmaceuticals, we are developing FIN-524 and FIN-525, orally administered, Targeted Consortia product candidates designed for the treatment of ulcerative colitis (UC) and Crohn’s ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Precision NanoSystems is a global leader in technologies, solutions and services for the development of non-viral delivery of genomic medicines, including mRNA vaccines and therapeutics. We work with the world’s leading drug developers to understand ...
Combining disruptive technology platforms with unparalleled genomic medicine development expertise, Precision NanoSystems’ Biopharmaceutical Services accelerates the development of lipid nanoparticle (LNP) formulations and drug products. ...
based inBethlehem, PENNSYLVANIA (USA)
Headquartered in Bethlehem, PA, Saladax Biomedical, Inc. is a privately held company that develops, manufactures, and markets assays that provide rapid therapeutic drug levels for essential and life-saving medicines prescribed by psychiatrists and ...
